ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,645Medicare Part D Prescriptions Filled, Including Refills

Rank: 178 out of 5176

$1.8M Total Retail Price of All Prescriptions

Rank: 70 out of 5176

763 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 16,167 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

57% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$108 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
AMLODIPINE BESYLATE 1,690 1,656 1 2
DIOVAN 711 668 2 19
METOPROLOL SUCCINATE 710 706 3 11
EVISTA 695 677 4 65
LOSARTAN POTASSIUM 535 521 5 14
ATORVASTATIN CALCIUM 504 495 6 9
CRESTOR 500 495 7 15
SIMVASTATIN 492 473 8 1
NEXIUM 471 464 9 16
CARVEDILOL 468 441 10 24
PLAVIX 341 323 11 29
ATENOLOL 341 325 11 12
DIGOXIN 331 326 13 56
LIDODERM 311 303 14 59
ALENDRONATE SODIUM 280 275 15 18
LOVAZA 265 257 16 43
ACTONEL 253 250 17 134
WARFARIN SODIUM 250 240 18 13
ISOSORBIDE MONONITRATE ER 243 243 19 44
CLOPIDOGREL 235 225 20 26
LIPITOR 231 229 21 51
GLIMEPIRIDE 231 213 21 37
BENICAR 216 216 23 100
NIZATIDINE 160 159 10 24 430
COUMADIN 160 155 24 112
OMEPRAZOLE 146 140 26 3
FAMOTIDINE 133 130 27 58
METFORMIN HCL 132 118 28 7
DIOVAN HCT 128 128 29 39
PRAVASTATIN SODIUM 125 124 30 23
ZOLPIDEM TARTRATE 120 120 31 17
ZETIA 120 120 31 68
CLOBETASOL PROPIONATE 120 120 31 130
LISINOPRIL 117 110 34 5
TAMSULOSIN HCL 114 111 35 20
DILTIAZEM 24HR CD 111 111 36 119
BYSTOLIC 103 103 37 96
RAMIPRIL 102 102 38 50
PROMETHAZINE HCL 93 90 R 39 221
HYDROCHLOROTHIAZIDE 93 93 39 10
FUROSEMIDE 92 92 41 8
CLONIDINE HCL 91 89 42 79
COLCRYS 89 89 43 170
PANTOPRAZOLE SODIUM 88 88 44 61
PRADAXA 87 87 45 192
EFFIENT 85 80 46 342
CELEBREX 83 82 47 80
LOSARTAN-HYDROCHLOROTHIAZIDE 82 82 48 35
JANUVIA 81 81 49 25
LANSOPRAZOLE 76 76 50 113
TRICOR 75 61 51 148
TRILIPIX 75 74 51 187
ALLOPURINOL 73 73 53 41
NIFEDIPINE ER 71 67 54 48
BISOPROLOL-HYDROCHLOROTHIAZIDE 67 67 55 164
POLYETHYLENE GLYCOL 3350 66 66 56 74
PATANOL 64 59 57 158
AZITHROMYCIN 64 62 57 42
MECLIZINE HCL 61 61 59 81
NASONEX 61 61 59 178
TRIAMCINOLONE ACETONIDE 60 58 61 125
FLUOCINONIDE 58 58 62 165
NITROSTAT 57 56 63 205
AVODART 51 51 64 107
QUINAPRIL HCL 51 51 64 82
GLIPIZIDE XL 50 50 66 83
TERAZOSIN HCL 50 45 66 158
TAMIFLU 50 48 66 231
MICARDIS 50 50 66 154
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.